Rebuma Belete1, Zerihun Ataro2, Ahmedmenewer Abdu2, Merga Sheleme3. 1. Department of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia. rebuma.belete2016@gmail.com. 2. Department of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia. 3. School of Medicine, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Abstract
BACKGROUND: The presence of metabolic syndrome among diabetes patients is frequent and is associated with an increased incidence of chronic complications and mortality. Despite several studies have been conducted, there is no overall estimation on the prevalence of metabolic syndrome among type 1 diabetic patients. Therefore, this study aimed to estimate the pooled prevalence of metabolic syndrome among patients with type 1 diabetes mellitus. METHODS: Medline via PubMed, CINAHL, ScienceDirect, Ovid, Google Scholar, ResearchGate and African Journals Online were searched by limiting publication period from January 2005 to October 2020. Data were extracted with a standardized format prepared in Microsoft Excel and exported to Stata 16.0 for analyses. The I2 statistic was used to check heterogeneity across the included studies. DerSimonian and Laird random-effects model was applied to estimate pooled prevalence and 95% confidence interval across studies. Funnel plot symmetry, Begg's test and Egger's regression test were used to determine the presence of publication bias. Subgroup and sensitivity analysis as well as meta-regression were conducted to explore the potential sources of heterogeneity. The study protocol is registered on PROSPERO with reference number: CRD42020213435. RESULTS: In this meta-analysis, a total of 27 studies with 45,811 study participants were included. The pooled prevalence of metabolic syndrome was 23.7% with substantial heterogeneity (I2 = 98.2%; P < 0.001). Geographical-based subgroup analysis revealed that the highest prevalence was observed in Australia (27.3%). As per meta-analysis of 17 studies, the pooled prevalence of metabolic syndrome in female type 1 diabetes patients (25.9%) was slightly higher than male T1DM patients (22.5%). CONCLUSION: Nearly a quarter of the type 1 diabetes mellitus patients were affected by metabolic syndrome. Therefore, more attention should be paid to the prevention and control of the epidemic and for the reduction of the morbidity and mortality associated with metabolic syndrome among type 1 diabetes mellitus patients.
BACKGROUND: The presence of metabolic syndrome among diabetespatients is frequent and is associated with an increased incidence of chronic complications and mortality. Despite several studies have been conducted, there is no overall estimation on the prevalence of metabolic syndrome among type 1 diabeticpatients. Therefore, this study aimed to estimate the pooled prevalence of metabolic syndrome among patients with type 1 diabetes mellitus. METHODS: Medline via PubMed, CINAHL, ScienceDirect, Ovid, Google Scholar, ResearchGate and African Journals Online were searched by limiting publication period from January 2005 to October 2020. Data were extracted with a standardized format prepared in Microsoft Excel and exported to Stata 16.0 for analyses. The I2 statistic was used to check heterogeneity across the included studies. DerSimonian and Laird random-effects model was applied to estimate pooled prevalence and 95% confidence interval across studies. Funnel plot symmetry, Begg's test and Egger's regression test were used to determine the presence of publication bias. Subgroup and sensitivity analysis as well as meta-regression were conducted to explore the potential sources of heterogeneity. The study protocol is registered on PROSPERO with reference number: CRD42020213435. RESULTS: In this meta-analysis, a total of 27 studies with 45,811 study participants were included. The pooled prevalence of metabolic syndrome was 23.7% with substantial heterogeneity (I2 = 98.2%; P < 0.001). Geographical-based subgroup analysis revealed that the highest prevalence was observed in Australia (27.3%). As per meta-analysis of 17 studies, the pooled prevalence of metabolic syndrome in female type 1 diabetespatients (25.9%) was slightly higher than male T1DM patients (22.5%). CONCLUSION: Nearly a quarter of the type 1 diabetes mellituspatients were affected by metabolic syndrome. Therefore, more attention should be paid to the prevention and control of the epidemic and for the reduction of the morbidity and mortality associated with metabolic syndrome among type 1 diabetes mellituspatients.
Authors: Juan J Chillarón; Juana A Flores-Le-Roux; Alberto Goday; David Benaiges; María J Carrera; Jaume Puig; Juan F Cano-Pérez; Juan Pedro-Botet Journal: Rev Esp Cardiol Date: 2010-04 Impact factor: 4.753
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith Journal: Circulation Date: 2009-10-05 Impact factor: 29.690
Authors: Nayera E Hassan; Salwa M El Shebini; Sahar A El-Masry; Nihad H Ahmed; Ayat N Kamal; Ahmed S Ismail; Khadija M Alian; Mohammed I Mostafa; Mohamed Selim; Mahmoud A S Afify Journal: Sci Rep Date: 2022-10-14 Impact factor: 4.996
Authors: Leen Oyoun Alsoud; Nelson C Soares; Hamza M Al-Hroub; Muath Mousa; Violet Kasabri; Nailya Bulatova; Maysa Suyagh; Karem H Alzoubi; Waseem El-Huneidi; Bashaer Abu-Irmaileh; Yasser Bustanji; Mohammad H Semreen Journal: Metabolites Date: 2022-06-01
Authors: Marilia Brito Gomes; Deborah Conte; Karla Rezende Guerra Drummond; Felipe Mallmann; André Araújo Pinheiro; Franz Schubert Lopes Leal; Paulo Henrique Morales; Carlos Antonio Negrato Journal: Diabetol Metab Syndr Date: 2022-01-04 Impact factor: 3.320
Authors: Ya-Wen Chang; Fung-Chang Sung; Ya-Ling Tzeng; Chih-Hsin Mou; Peng-Tai Tien; Cheng-Wen Su; Yu-Kuei Teng Journal: Int J Environ Res Public Health Date: 2021-12-28 Impact factor: 3.390
Authors: Khalid M El-Say; Raed I Felimban; Hossam H Tayeb; Adeel G Chaudhary; Abdelsattar M Omar; Waleed Y Rizg; Fuad H Alnadwi; Fathy I Abd-Allah; Tarek A Ahmed Journal: Int J Nanomedicine Date: 2022-04-21